Jessica Gordon

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients

Lisa Rice, Cristina M. Padilla, Sarah McLaughlin et al. · Journal of Clinical Investigation · 2015 · 334 citations · Full text

Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8

Marie Dominique Ah Kioon, Claudio Tripodo, David Fernández et al. · Science Translational Medicine · 2018 · 233 citations · Full text

Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase <scp>II</scp> Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Trial

Dinesh Khanna, Cathie Spino, Sindhu R. Johnson et al. · Arthritis & Rheumatology · 2019 · 218 citations · Full text

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial

Robert Spiera, Jessica Gordon, Jamie Mersten et al. · Annals of the Rheumatic Diseases · 2011 · 173 citations · Full text

Survival and Predictors of Mortality in Systemic Sclerosis‐Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry

Robyn T. Domsic, Bharathi Lingala, Firas Alkassab et al. · Arthritis Care & Research · 2013 · 168 citations · Full text